CKPT - Checkpoint Therapeutics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 583.21M
Enterprise Value 370.01M
Trailing P/E N/A
Forward P/E 1-2.92
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)18.75
Price/Book (mrq)11.23
Enterprise Value/Revenue 315.77
Enterprise Value/EBITDA 6N/A

Trading Information

Stock Price History

Beta (3Y Monthly) 3.22
52-Week Change 3-46.24%
S&P500 52-Week Change 32.59%
52 Week High 35.2000
52 Week Low 31.5000
50-Day Moving Average 32.7189
200-Day Moving Average 33.3349

Share Statistics

Avg Vol (3 month) 3110.97k
Avg Vol (10 day) 351.04k
Shares Outstanding 531M
Float 23.14M
% Held by Insiders 121.74%
% Held by Institutions 110.34%
Shares Short (Aug 15, 2019) 4583.45k
Short Ratio (Aug 15, 2019) 412.47
Short % of Float (Aug 15, 2019) 42.58%
Short % of Shares Outstanding (Aug 15, 2019) 41.54%
Shares Short (prior month Jul 15, 2019) 4585.48k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-721.74%

Management Effectiveness

Return on Assets (ttm)-90.64%
Return on Equity (ttm)-214.45%

Income Statement

Revenue (ttm)4.44M
Revenue Per Share (ttm)0.14
Quarterly Revenue Growth (yoy)727.60%
Gross Profit (ttm)-30.15M
EBITDA N/A
Net Income Avi to Common (ttm)-31.64M
Diluted EPS (ttm)-1.0100
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)13.21M
Total Cash Per Share (mrq)0.35
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)1.90
Book Value Per Share (mrq)0.19

Cash Flow Statement

Operating Cash Flow (ttm)-27.23M
Levered Free Cash Flow (ttm)-17.63M